Skip to content

Clinical trials

Phase 3 Ischemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemia Phase: Phase 3 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20035
20043
20052
20064
20074
20083
20093
20102
20111
20152
20181
20193
20211
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated6
Unknown status5
Not yet recruiting2
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acusphere2
AstraZeneca2
Beijing Northland Biotech. Co., Ltd.2
Brian Silver2
Merck Sharp & Dohme LLC2
Pfizer2
Sangart2
Abbott Medical Devices1
Abiomed Inc.1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemia41
Stroke11
Myocardial Ischemia10
Coronary Artery Disease9
Arterial Occlusive Diseases6
Heart Diseases6
Cardiovascular Diseases5
Myocardial Infarction5
Angina Pectoris4
Brain Diseases4

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.